RasGRP1, also known as Calcium and DAG-regulated guanine nucleotide exchange factor II (CalDAG-GEFII) or Ras guanyl-releasing protein (RASGRP), and encoded by the gene RASGRP1/RASGRP, functions as a diacylglycerol (DAG)-regulated nucleotide exchange factor specifically activating Ras through the exchange of bound GDP for GTP. RasGRP1 activates the Erk/MAP kinase cascade and couples T-lymphocytes and B-lymphocytes antigen receptors to the activation of Ras. Hence, it regulates T-cells and B-cells development, homeostasis and differentiation. Additionally, RasGRP1 functions also in FcERI-evoked degranulation and cytokine secretion by mast cells, regulating allergic responses. RasGRP1 may also function in other cell types’ differentiation. RasGRP1 is localized to the cytoplasm and cell membrane; it is a peripheral membrane protein in the Golgi/ER membranes. In neurons, RasGRP1 localizes to somata and dendrites but not to axons of hippocampal pyramidal cells of in the brain and in particular the cerebellum, cortex and amygdata. RasGRP1 also is expressed in the hematopoietic system including T cells and RasGRP1 is also found expressed developmentally in fetal brain and kidney tissues. Defects in RasGRP1 may be associated with Systemic lupus erythematosus (SLE) a chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Interestingly it is thought that aberrantly spliced isoforms or other mutations of RASGRP1 give rise to dysregulation of various signaling processes which in turn contribute to the development of autoimmunity in SLE patients.
면역원
GST-tagged recombinant protein corresponding to human RasGRP1.
애플리케이션
Detect RasGRP1 using this mouse monoclonal antibody, Anti-RasGRP1 Antibody & clone 10.1 validated for use in western blotting.
Western Blotting Analysis: 1.0 µg/mL from a representative lot detected RasGRP1 in 10 µg of human cerebellum tissue lysate. Flow Cytometry Analysis: A representative lot detected RasGRP1 in malignant lymphoid cells treated with tipifarmib (Ding, H., et al. (2011). Blood. 118:4872-4881).
품질
Evaluated by Western Blotting in MOLT-4 cell lysate.
Western Blotting Analysis: 1.0 µg/mL of this antibody detected RasGRP1 in 10 µg of MOLT-4 cell lysate.
표적 설명
~90 kDa observed. Uniprot describes 3 isoforms produced by alternative splicing at ~62 kDa, ~55 kDa, and ~68 kDa
물리적 형태
Format: Purified
기타 정보
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
적합한 제품을 찾을 수 없으신가요?
당사의 제품 선택기 도구.을(를) 시도해 보세요.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 1
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
Schizophrenia (SCZ) is a polygenic severe mental illness. Genome-wide association studies (GWAS) have detected genomic variants associated with this psychiatric disorder and pathway analyses have indicated immune system and dopamine signaling as core components of risk in dorsolateral-prefrontal cortex (DLPFC)
Inherited CTPS1, CD27, and CD70 deficiencies in humans have revealed key factors of T-lymphocyte expansion, a critical prerequisite for an efficient immunity to Epstein-Barr virus (EBV) infection. RASGRP1 is a T-lymphocyte-specific nucleotide exchange factor known to activate the pathway of
The striatum of the brain coordinates motor function. Dopamine-related drugs may be therapeutic to patients with striatal neurodegeneration, such as Huntington's disease (HD) and Parkinson's disease (PD), but these drugs have unwanted side effects. In addition to stimulating the release
The therapeutic effects of l-3,4-dihydroxyphenylalanine (l-DOPA) in patients with Parkinson's disease (PD) severely diminishes with the onset of abnormal involuntary movement, l-DOPA-induced dyskinesia (LID). However, the molecular mechanisms that promote LID remain unclear. Here, we demonstrated that RasGRP1 [(guanine nucleotide
질문
후기
★★★★★ 평점 값 없음
활성 필터
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..